GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Express Scripts Holding Co (NAS:ESRX) » Definitions » EV-to-EBITDA

Express Scripts Holding Co (Express Scripts Holding Co) EV-to-EBITDA : 7.08 (As of Apr. 26, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Express Scripts Holding Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Express Scripts Holding Co's enterprise value is $52,061 Mil. Express Scripts Holding Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2018 was $7,351 Mil. Therefore, Express Scripts Holding Co's EV-to-EBITDA for today is 7.08.

The historical rank and industry rank for Express Scripts Holding Co's EV-to-EBITDA or its related term are showing as below:

ESRX's EV-to-EBITDA is not ranked *
in the Healthcare Plans industry.
Industry Median: 8.49
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-26), Express Scripts Holding Co's stock price is $92.33. Express Scripts Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2018 was $8.560. Therefore, Express Scripts Holding Co's PE Ratio for today is 10.79.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Express Scripts Holding Co EV-to-EBITDA Historical Data

The historical data trend for Express Scripts Holding Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Express Scripts Holding Co EV-to-EBITDA Chart

Express Scripts Holding Co Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.29 12.53 10.64 7.55 7.63

Express Scripts Holding Co Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.56 7.63 7.09 7.63 8.80

Competitive Comparison of Express Scripts Holding Co's EV-to-EBITDA

For the Healthcare Plans subindustry, Express Scripts Holding Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Express Scripts Holding Co's EV-to-EBITDA Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Express Scripts Holding Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Express Scripts Holding Co's EV-to-EBITDA falls into.



Express Scripts Holding Co EV-to-EBITDA Calculation

Express Scripts Holding Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=52061.190/7350.8
=7.08

Express Scripts Holding Co's current Enterprise Value is $52,061 Mil.
Express Scripts Holding Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $7,351 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Express Scripts Holding Co  (NAS:ESRX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Express Scripts Holding Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=92.33/8.560
=10.79

Express Scripts Holding Co's share price for today is $92.33.
Express Scripts Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.560.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Express Scripts Holding Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Express Scripts Holding Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Express Scripts Holding Co (Express Scripts Holding Co) Business Description

Traded in Other Exchanges
N/A
Address
Express Scripts is the largest pharmacy benefit manager in the United States. Through its mail-order pharmacy and network of retail pharmacies, Express Scripts processes approximately 1.3 billion adjusted prescriptions annually for its payer clients.